Methotrexate model of Hepatotoxicity: A Review | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.


Methotrexate model of Hepatotoxicity: A Review

Author(s): Deepika Bhatia* and Dr Pradeep Goyal

The liver is an important organ for maintenance of body general function and homeostasis. In addition to its role in the digestive process, it is important to detoxify unwanted substances. There are many varieties of drugs and chemicals are used to shows a toxic effect on liver e.g. ccl4, Peracetamol, Glactosamine, Methotrexate and many more at different dose. In this review we are going to discuss the toxic dose of methotrexate causes hepatotoxicity. Methotrexate (Mtx) is a antagonist of folic acid and also a cytotoxic agent that is responsible to inhibit cellular growth. It is used in many clinical symptoms i.eleukemia, lymphomas etc. The present overview summarizes some of the basic concepts involved in hepatotoxicity, their preclinical evaluation methods and some hepatotoxic models based upon dose.

Full-Text PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 25868

Der Pharma Chemica received 25868 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry